| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | See Remarks
5 companies
Zeldis Jerome B is a Director at STEX with holdings across 5 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2019 | SNGX Soligenix, Inc. | Director | Buy | 2,000 | $0.93 | $1,850.00 | +9.6% | |
| Sep 19, 2019 | SNGX Soligenix, Inc. | Director | Buy | 4,000 | $0.94 | $3,740.00 | +23.6% | |
| Apr 22, 2019 | SNGX Soligenix, Inc. | Director | Buy | 10,000 | $0.73 | $7,274.00 | +144.6% | |
| Feb 3, 2017 | SRNE Sorrento Therapeutics, Inc. | See Remarks | Buy | 10,000 | $5.15 | $51,500.00 | New | |
| Dec 23, 2015 | SNGX Soligenix, Inc. | Director | Buy | 2,500 | $1.27 | $3,175.00 | +3.8% |